LARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for LARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise in larynx cancer without surgery
Disease control OngoingThis study tested a combination of two chemotherapy drugs (cisplatin and docetaxel) plus an immunotherapy drug (pembrolizumab) in 28 patients with stage II or III laryngeal cancer. The goal was to see if this drug-only approach could control the cancer and avoid the need for surg…
Matched conditions: LARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug combo aims to improve head and neck cancer outcomes
Disease control OngoingThis study tests whether adding two drugs, pembrolizumab and olaparib, before and after standard chemoradiation can help control locally advanced head and neck cancer. About 45 adults with this cancer will receive the drug combination. The main goal is to see if this approach imp…
Matched conditions: LARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New CT scanner could sharpen view of throat cancer
Diagnosis ENROLLING_BY_INVITATIONThis study tests a new type of CT scan, called Photon-Counting CT, to see if it can more accurately show how far laryngeal cancer has spread. Sixty adults with laryngeal cancer will get this scan while making a sound, which may help separate normal tissues from tumor. The goal is…
Matched conditions: LARYNGEAL SQUAMOUS CELL CARCINOMA
Sponsor: Humanitas University • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC